Antibiotice Iași (ATB) reported total revenues of 498.21 million lei in the first 3 quarters, a decrease of 2.51% compared to the previous year. International sales contributed 202.60 million lei. Total expenses increased by 6.57%, reaching 446.39 million lei. The company recorded a net profit of 42.64 million lei, which is 51.50% lower compared to 87.93 million lei in the same period of 2024. Total assets increased by 9.47% to 1.40 billion lei, while liabilities rose by 24.02%, reaching 477.40 million lei. Antibiotice Iași is 53.02% owned by the Ministry of Health and is listed on the Bucharest Stock Exchange, with a market capitalization of 1.72 billion lei.
Sources
Antibiotice Iași își înjumătățește profitul net
Profitul Antibiotice Iaşi s-a înjumătăţit la nouă luni, pe fondul scăderii vânzărilor interne şi al creşterii costurilor de producţie
Antibiotice Iași continuă să exporte substanțial și majorează investițiile. Veniturile la intern scad din cauza inflației în creștere-Rezultate 9 luni 2025
Latest News
19:16
Italy expelled Moldovan artist “Bratan”, accused of blocking a motorway to film a music video
19:00
The Capital City Hall could prohibit minors from accessing rental scooters and penalize their illegal parking
18:51
WSJ: U.S. Ambassador to Greece Reportedly Backed Bulgaria’s Purchase of American LNG
18:40
The Romanian Gendarmerie is organizing an exercise in Romania with more than 500 soldiers and gendarmes from 19 countries
18:24
Siegfried Mureșan, following the WSJ revelations: Next week’s vote is an opportunity for the PSD and Grindeanu to prove that they are “good Romanians”
See more news